Pharmaceuticals and Healthcare

Head and neck Cancer – Pipeline Review, H1 2016 $2500

Head and neck Cancer – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Head And Neck Cancer – Pipeline Review, H1 2016’, provides an overview of the Head And Neck ...Read the full article

27th April, 2016 • Global Markets Direct

 

Basal Cell Carcinoma (Basal Cell Epithelioma) – Pipeline Review, H1 2016 $2000

Basal Cell Carcinoma (Basal Cell Epithelioma) – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) – Pipeline Review, H1 2016’, provides an overview of ...Read the full article

27th April, 2016 • Global Markets Direct

 

Enterocolitis – Pipeline Review, H1 2016 $2000

Enterocolitis – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Enterocolitis – Pipeline Review, H1 2016’, provides an overview of the Enterocolitis pipeline landscape. The report provides comprehensive information on ...Read the full article

27th April, 2016 • Global Markets Direct

 

KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) – Pipeline Review, H1 2016 $3500

KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) – Pipeline Review, H1 2016 ...Read the full article

27th April, 2016 • Global Markets Direct

 

Gastric Cancer – Pipeline Review, H1 2016 $2000

Gastric Cancer – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Gastric Cancer – Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Allergic Conjunctivitis – Pipeline Review, H1 2016 $2000

Allergic Conjunctivitis – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Allergic Conjunctivitis – Pipeline Review, H1 2016’, provides an overview of the Allergic Conjunctivitis pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Neurofibromatoses Type II – Pipeline Review, H1 2016 $2000

Neurofibromatoses Type II – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II – Pipeline Review, H1 2016’, provides an overview of the Neurofibromatoses Type II pipeline landscape. ...Read the full article

27th April, 2016 • Global Markets Direct

 

Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) – Pipeline Review, H1 2016 $3500

Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide ...Read the full article

27th April, 2016 • Global Markets Direct

 

Fallopian Tube Cancer – Pipeline Review, H1 2016 $2000

Fallopian Tube Cancer – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fallopian Tube Cancer – Pipeline Review, H1 2016’, provides an overview of the Fallopian Tube Cancer pipeline landscape. ...Read the full article

27th April, 2016 • Global Markets Direct

 

Angina (Angina Pectoris) – Pipeline Review, H1 2016 $2000

Angina (Angina Pectoris) – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Angina (Angina Pectoris) – Pipeline Review, H1 2016’, provides an overview of the Angina (Angina Pectoris) pipeline landscape. ...Read the full article

27th April, 2016 • Global Markets Direct

 

Essential Thrombocythemia – Pipeline Review, H1 2016 $2000

Essential Thrombocythemia – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Essential Thrombocythemia – Pipeline Review, H1 2016’, provides an overview of the Essential Thrombocythemia pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) – Pipeline Review, H1 2016 $3500

Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Nociceptin Receptor (Kappa-Type ...Read the full article

27th April, 2016 • Global Markets Direct

 

Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2016 $2000

Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2016’, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape. ...Read the full article

27th April, 2016 • Global Markets Direct

 

Equine Encephalitis – Pipeline Review, H1 2016 $2000

Equine Encephalitis – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Equine Encephalitis – Pipeline Review, H1 2016’, provides an overview of the Equine Encephalitis pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Pheochromocytoma – Pipeline Review, H1 2016 $2000

Pheochromocytoma – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pheochromocytoma – Pipeline Review, H1 2016’, provides an overview of the Pheochromocytoma pipeline landscape. The report provides comprehensive information on ...Read the full article

27th April, 2016 • Global Markets Direct

 

Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) – Pipeline Review, H1 2016 $3500

Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) – Pipeline Review, ...Read the full article

27th April, 2016 • Global Markets Direct

 

Relapsed Acute Myeloid Leukemia – Pipeline Review, H1 2016 $2000

Relapsed Acute Myeloid Leukemia – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia – Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid ...Read the full article

27th April, 2016 • Global Markets Direct

 

Narcolepsy – Pipeline Review, H1 2016 $2000

Narcolepsy – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Narcolepsy – Pipeline Review, H1 2016’, provides an overview of the Narcolepsy pipeline landscape. The report provides comprehensive information on ...Read the full article

27th April, 2016 • Global Markets Direct

 

Guillain-Barre Syndrome – Pipeline Review, H1 2016 $2000

Guillain-Barre Syndrome – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Guillain-Barre Syndrome – Pipeline Review, H1 2016’, provides an overview of the Guillain-Barre Syndrome pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Clostridium difficile Infections (Clostridium difficile Associated Disease) – Pipeline Review, H1 2016 $2000

Clostridium difficile Infections (Clostridium difficile Associated Disease) – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Clostridium difficile Infections (Clostridium difficile Associated Disease) – Pipeline Review, H1 2016’, provides an ...Read the full article

27th April, 2016 • Global Markets Direct

 

Epidermolysis Bullosa – Pipeline Review, H1 2016 $2000

Epidermolysis Bullosa – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Epidermolysis Bullosa – Pipeline Review, H1 2016’, provides an overview of the Epidermolysis Bullosa pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Bronchiectasis – Pipeline Review, H1 2016 $2000

Bronchiectasis – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Bronchiectasis – Pipeline Review, H1 2016’, provides an overview of the Bronchiectasis pipeline landscape. The report provides comprehensive information on ...Read the full article

27th April, 2016 • Global Markets Direct

 

Acne Vulgaris – Pipeline Review, H1 2016 $2000

Acne Vulgaris – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acne Vulgaris – Pipeline Review, H1 2016’, provides an overview of the Acne Vulgaris pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Hematopoietic Stem Cell Transplantation – Pipeline Review, H1 2016 $2000

Hematopoietic Stem Cell Transplantation – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation – Pipeline Review, H1 2016’, provides an overview of the Hematopoietic Stem Cell ...Read the full article

27th April, 2016 • Global Markets Direct

 

Ache Laboratorios Farmaceuticos S/A – Product Pipeline Review – 2016 $1500

Ache Laboratorios Farmaceuticos S/A – Product Pipeline Review – 2016 Summary Global Markets Direct’s, ‘Ache Laboratorios Farmaceuticos S/A – Product Pipeline Review – 2016’, provides an overview of the Ache ...Read the full article

27th April, 2016 • Global Markets Direct

 

Sickle Cell Disease – Pipeline Review, H1 2016 $2000

Sickle Cell Disease – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Sickle Cell Disease – Pipeline Review, H1 2016’, provides an overview of the Sickle Cell Disease pipeline landscape. ...Read the full article

27th April, 2016 • Global Markets Direct

 

Keratitis – Pipeline Review, H1 2016 $2000

Keratitis – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Keratitis – Pipeline Review, H1 2016’, provides an overview of the Keratitis pipeline landscape. The report provides comprehensive information on ...Read the full article

27th April, 2016 • Global Markets Direct

 

Anacor Pharmaceuticals, Inc. – Product Pipeline Review – 2016 $1500

Anacor Pharmaceuticals, Inc. – Product Pipeline Review – 2016 Summary Global Markets Direct’s, ‘Anacor Pharmaceuticals, Inc. – Product Pipeline Review – 2016’, provides an overview of the Anacor Pharmaceuticals, Inc.’s ...Read the full article

27th April, 2016 • Global Markets Direct

 

Osteoarthritis Pain – Pipeline Review, H1 2016 $2000

Osteoarthritis Pain – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Osteoarthritis Pain – Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis Pain pipeline landscape. The report provides ...Read the full article

27th April, 2016 • Global Markets Direct

 

Rosacea – Pipeline Review, H1 2016 $2000

Rosacea – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Rosacea – Pipeline Review, H1 2016’, provides an overview of the Rosacea pipeline landscape. The report provides comprehensive information on ...Read the full article

27th April, 2016 • Global Markets Direct

 

Let’s get started...

Broker Rating Markets Available Fees Open an Account
Kawase Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 3.60 /5
(15 votes cast)
Loading...
Shares, Indices, Forex and Oil Spread From 0.1 and 0.2% Commission Visit Website
Plus500 Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 4.48 /5
(452 votes cast)
Loading...
Stocks, Commodities, Indices and Forex. Zero commissions. No monthly fees. $10 USD fee for unused account for a period of three months. Visit Website
MaxFx Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 4.70 /5
(89 votes cast)
Loading...
Indices, Forex, Metals, Shares From 0.1 Raw Interbank Spread Visit Website
Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.